Cholesteryl Ester Transfer Protein Inhibitor Torcetrapib and Off-Target Toxicity: A Pooled Analysis of the Rating Atherosclerotic Disease Change by Imaging With a New CETP Inhibitor (RADIANCE) Trials
Circulation Vergeer et al.
118: 2515
Correction
In the version of the article, “Cholesteryl Ester Transfer Protein Inhibitor Torcetrapib and Off-Target Toxicity: A Pooled Analysis of the Rating Atherosclerotic Disease Change by Imaging With a New CETP Inhibitor (Radiance) Trials,” by Menno Vergeer et al that was posted online on November 24, 2008 (DOI: 10.1161/CIRCULATIONAHA.108.772665), an error occurred.
In the Abstract, the full name of the RADIANCE trial was incorrect. It should be, “Rating Atherosclerotic Disease Change by Imaging With a New CETP Inhibitor.”
The error has been corrected in the current online version and in the final print version of the article in the December 9, 2008, issue of the journal (Circulation. 2008;118:2515-2522). The publisher regrets the error.